Pre-Market Stock News (October 15, 2007)

Print Email

(APC) Anadarko filed for a spin-off of its Western Gas Partners LP.
(BIIB) Biogen-Idec trading up 18% after announcing it was putting itself up for sale.
(C) Citigroup $0.47 EPS vs. $0.44 est.; stock up 1% pre-market.
(CMED) China Medical Tech received Korean FDA approval for its HIFU system.
(CRA) Celera Genomics and collaboration team identified a risk score to predict genetic coronary disease.
(ELN) Elan hired Lehman for advice on Tysabri review extension from FDA; stock up over 10%.
(ETN) Eaton $1.67 EPS vs $1.68 est.
(GENZ) Genzyme presented positive results from Phase II of Alemtuzumab in Multiple Sclerosis studies.
(GLGC) Gene Logic agrees to sell its Genomics assets.
(MAT) Mattel $0.61 EPS vs $0.70 est, although that number includes some charges; stock down almost 1%.
(MDT) Medtronic suspended distribution of Sprint Fidelis(R) defibrillation leads on voluntary basis.
(NWS) News Corp.’s Fox Business News launches today.
(PCOP) Pharmacopeia acquired a selective androgen receptor modulator program from Bristol-Myers Squibb.
(PRM) Primedia put full year revenue guidance flat to low single digits versus previous "low single digit" guidance.
(TEK) Textronix gets $38 buyout from Danaher (DHR) in a $2.8 Billion deal.
(TELK) Telik said the FDA removed a partial hold on TELCYTA clinical development; stock up nearly 20%.
(VSAT) ViaSat was awared an $8.7 million contract to modernize Air Force telemetry tracking and control cryptographic units.
(WNG) Washington Group raised guidance.

Jon C. Ogg
October 15, 2007